clarithromycin has been researched along with minocycline in 104 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (25.96) | 18.2507 |
| 2000's | 44 (42.31) | 29.6817 |
| 2010's | 32 (30.77) | 24.3611 |
| 2020's | 1 (0.96) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Sasaki, T; Takahata, M; Yamazaki, T | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chiba, N; Hasegawa, K; Iwata, S; Matsubara, K; Morozumi, M; Nakayama, E; Sunakawa, K; Takayanagi, R; Ubukata, K | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Ishikawa, C; Konishi, H; Nakagawa, N; Tsuda, T; Yamanishi, K | 1 |
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 1 |
| Hamasuna, R; Jensen, JS; Osada, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cohen, Y; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
| Grosset, JH; Ji, B; Perani, EG; Petinon, C | 1 |
| Caroff, B; Chau, F; Derouin, F; Pocidalo, JJ; Prokocimer, P | 1 |
| Araujo, FG; Prokocimer, P; Remington, JS | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
| Grosset, JH; Ji, B; Perani, EG | 1 |
| Chehl, SK; Gelber, RH; Murray, LP; Richard, V; Siu, P; Tsang, M | 1 |
| Lacassin, F; Leport, C; Longuet, P; Perronne, C; Schaffo, D; Vilde, JL | 1 |
| Dhoore, F; Verbist, L | 1 |
| Alder, J; Clement, JC; Hutch, T; Meulbroek, JA | 1 |
| Chauvin, JP; Dautzenberg, B; Durant, J; Legrand, MF; Meyohas, MC; Reynes, J; Saint-Marc, T; Truffot, C | 1 |
| Grosset, JH; Ji, B; Perani, EG; Pétinon, C; Xiong, JH | 1 |
| Grosset, J; Lazard, T; Perronne, C; Pocidalo, JJ; Vilde, JL | 1 |
| Dupont, B; Goldstein, F; Gonzalez Canali, G; Pialoux, G; Sansonetti, P | 1 |
| Bobin, P; Grosset, JH; Jamet, P; Ji, B; Perani, EG | 1 |
| Derouin, F; Pudney, M; Romand, S | 1 |
| Ellis, W; Fayer, R | 1 |
| Gidoh, M; Saito, H | 1 |
| Amiel, C; Canton, P; Hoen, B; May, T; Rabaud, C; Sellal, A | 1 |
| Grosset, JH; Ji, B; Perani, EG; Petinom, C | 1 |
| Grosset, JH; Jamet, P; Ji, B; Lienhardt, C; Perani, EG; Petinon, C; Sow, S | 1 |
| Igual, J; Roussel, G | 1 |
| Matsushima, T; Miyashita, N | 1 |
| Cannon, BM; Conerly, LL; Dajcs, JJ; Hill, JM; Hume, EB; Moreau, JM; O'Callaghan, RJ | 1 |
| Gidoh, M | 1 |
| Barchiesi, F; Cirioni, O; Fortuna, M; Giacometti, A; Scalise, G | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Matsumoto, A; Matsushima, T; Miyashita, N | 1 |
| Hatakeyama, S; Oka, T; Suzuki, K; Tachibana, A; Tateda, K; Yamaguchi, K | 1 |
| Fujiue, Y; Itaha, H; Kashiyama, S; Kohara, T; Kuwabara, M; Muroki, K; Onimura, K; Sasaki, M; Shigemitsu, M; Yamasaki, M | 1 |
| Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Rea, TH | 1 |
| Bañuls, J; Betlloch, I; Botella, R; Navas, J; Pascual, E; Ramón, R | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Araujo, MV; de Nucci, G; Ifa, DR; Moraes, ME; Moraes, MO; Ribeiro, W | 1 |
| Ashihara, E; Fujita, N; Hatsuse, M; Inaba, T; Nakagawa, M; Noda, Y; Ochiai, N; Okano, A; Shimazaki, C; Takahashi, R | 1 |
| Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Ishitobi, H; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Friedman, H; Yamaguchi, H; Yamamoto, M; Yamamoto, Y; Yasuda, K | 1 |
| Hata, K; Hisamori, S; Inoue, T; Ishimaru, H; Katoh, K; Maeda, Y; Maniwa, K; Minaguchi, M; Oida, K; Sakuramoto, M; Taguchi, Y; Tanaka, E; Terada, K | 1 |
| Baba, T; Ikehara, K; Ishigatsubo, Y; Kaneko, T; Kusano, N; Nishiyama, H; Shinohara, T; Shoji, A; Suzuki, S; Tagawa, A; Tsuburai, T | 1 |
| Inoue, K; Kumakura, S; Tsutsui, T; Uchida, M | 1 |
| Bormann, G; Marsch, WC | 1 |
| Shigeto, N; Shimizu, S | 1 |
| Hasegawa, A; Ito, M; Kano, R; Kashima, M; Mikami, Y; Mizoguchi, M; Takahama, H | 1 |
| Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
| Abe, T; Arita, T; Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S; Watanabe, K | 1 |
| Asano, Y; Idezuki, T; Igarashi, A | 1 |
| Petrini, B | 1 |
| Baba, K; Hara, K; Hattori, T; Matsui, S; Niwa, S; Onoe, K; Ozawa, H; Yagi, T; Yamaguchi, E | 1 |
| Sarma, DP; Shehan, JM | 1 |
| Ando, S; Inoue, M; Kishimoto, T; Ogawa, M; Sato, K; Takemura, H; Yamazaki, T | 1 |
| Hidaka, H; Kubota, T; Kubuta, T; Nakao, Y; Nishio, N | 1 |
| Iwatsuki, K; Kobayashi, T; Wakabayashi, H; Yaeshima, T; Yamauchi, K; Yoshie, H | 1 |
| Henning, JS; Johnson, RP; Schwendiman, MN | 1 |
| Asami, R; Chiba, N; Morozumi, M; Murayama, SY; Okada, T; Takahashi, T; Ubukata, K | 1 |
| Cesar, GE; Fujita, Y; Fukuda, K; Horiki, N; Iizuka, Y; Imoto, I; Ishii, N; Ito, T; Katsurahara, M; Omata, F; Suzuki, S; Takei, Y; Uemura, M | 1 |
| Bono, BR; Qamar, F; Zuckerman, JM | 1 |
| Hsueh, PR; Lee, PI; Yang, JC | 1 |
| Butler, G; Ricciardo, B; Weedon, D | 1 |
| Bricaire, F; Caumes, E; Monsel, G; Roujeau, JC; Schneider, P; Veziris, N | 1 |
| Girdhar, A; Girdhar, BK; Kumar, A | 1 |
| Wang, CP; Xu, XL; Zeng, XH; Zhou, M; Zhou, Y | 1 |
| Caron, J; Dereure, O; Fabre, S; Godreuil, S; Guillot, B; Michot, C | 1 |
| Borisevich, SV; Iakovlev, EA; Lukin, EP | 1 |
| Chen, JH; Hu, ST; Huang, CC; Huang, CW; Huang, WC; Lee, YC; Shen, GH | 1 |
| Akaike, H; Kato, A; Kawai, Y; Kawasaki, K; Kondo, E; Kubo, M; Miyashita, N; Nakano, T; Nishizawa, Y; Ogita, S; Ouchi, K; Saito, A; Tanaka, T; Terada, K; Teranishi, H | 1 |
| Carter, ER; Iwanaga, K | 1 |
| Campos Gutierrez, S; Díaz Cuevas, Z; Lecuona Fernández, M; Rodríguez-Lozano, B | 1 |
| Bajwa, G; Hirose, H; Karbowski, P; Miessau, J; Unai, S | 1 |
| Alves, SH; Bizzi, K; Ferreiro, L; Jesus, FP; Loreto, ÉS; Ludwig, A; Pilotto, MB; Santurio, JM; Tondolo, JS; Zanette, RA | 1 |
| Alves, SH; Loreto, ES; Pilotto, MB; Santurio, JM; Tondolo, JS | 1 |
| Fujii, T; Ito, A; Nakaminami, H; Noguchi, N; Utsumi, K | 1 |
| Bai, P; Ding, Y; Luo, Y; Xiao, XM; Zhou, LY | 1 |
| Alves, SH; Azevedo, MI; Driemeier, D; Ferreiro, L; França, RT; Jesus, FP; Lopes, ST; Loreto, ÉS; Ludwig, A; Pilotto, MB; Ribeiro, TC; Santurio, JM; Souza, SO; Tondolo, JS | 1 |
| Bakker-Woudenberg, IA; Bax, HI; de Steenwinkel, JE; Ten Kate, MT; Verbon, A | 1 |
| Bai, P; Ding, Y; Song, Z; Zhang, L; Zhou, L | 1 |
| Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N | 1 |
| Aoyagi, H; Ariga, T; Furuyama, H; Hara, K; Hazama, K; Horino, A; Ishiguro, N; Ishizaka, A; Kaiho, M; Kenri, T; Kikuta, H; Koseki, N; Morita, K; Nagano, N; Naito, H; Nakanishi, M; Oba, K; Sasaki, S; Shibata, M; Shida, S; Tabata, Y; Togashi, T; Watanabe, T; Yamanaka, T; Yoshioka, M | 1 |
| Neal, D; Taylor, M; Taylor, S | 1 |
| Brouqui, P; Drancourt, M; Quenard, F | 1 |
| Chang, CT; Doerr, KM; Whipps, CM | 1 |
| Chen, NY; Chiu, CH; Chung, WH; Kuo, AJ; Lai, HC; Lee, MC; Liu, TP; Lu, JJ; Sun, PL; Wang, LH; Wu, TL; Wu, TS; Yang, CH; Yang, JH | 1 |
| Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
| Adams, LB; Collins, JH; Hagge, DA; Lahiri, R; Lenz, SM; Ray, NA | 1 |
12 review(s) available for clarithromycin and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Present status of studies on antileprosy drugs].
Topics: Animals; Clarithromycin; Dapsone; Drug Therapy, Combination; Humans; Immunologic Factors; Leprostatic Agents; Minocycline; Prothionamide; Quinolones; Rifampin; Rifamycins; Thalidomide | 1995 |
[Basic and clinical study of Chlamydia pneumoniae infections].
Topics: Anti-Bacterial Agents; Arteriosclerosis; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Humans; Minocycline | 1998 |
[The control leprous peripheral neuropathy and chemotherapy].
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Leprostatic Agents; Leprosy; Minocycline; Peripheral Nervous System Diseases; Protein Synthesis Inhibitors; Rats; Roxithromycin | 1999 |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debridement; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Skin Ulcer; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Omeprazole; Rabeprazole; Treatment Failure | 2002 |
[Eradication of Helicobacter pylori for idiopathic thrombocytopenic purpura].
Topics: Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Minocycline; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries | 2006 |
Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides; Minocycline; Tetracyclines; Tigecycline | 2009 |
[Present stage of chemotherapy and chemoprophylaxis of rickettsiosis and Q fever].
Topics: Anti-Bacterial Agents; Chemoprevention; Chloramphenicol; Clarithromycin; Doxycycline; Female; Fluoroquinolones; Humans; Macrolides; Minocycline; Pregnancy; Pregnancy Complications, Infectious; Q Fever; Rickettsia Infections; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Sternal wound infection caused by Mycobacterium chelonae.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Heart Atria; Heart Neoplasms; Humans; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myxoma; Pectoralis Muscles; Sternotomy; Sternum; Surgical Flaps; Surgical Wound Infection; Thoracic Surgical Procedures; Tigecycline; Treatment Outcome | 2013 |
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Minocycline; Mycobacterium tuberculosis; Phenothiazines; Sulfonamides | 2017 |
10 trial(s) available for clarithromycin and minocycline
| Article | Year |
|---|---|
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Child; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Hearing Disorders; Humans; Liver Function Tests; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Recurrence; Treatment Outcome | 1994 |
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Female; Humans; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae | 1993 |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Leprosy, Lepromatous; Male; Mice; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Skin | 1996 |
Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Leukopenia; Male; Minocycline; Recurrence; Rifampin | 2000 |
Determination of minocycline in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry: application to bioequivalence study.
Topics: Administration, Oral; Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressure Liquid; Clarithromycin; Food-Drug Interactions; Humans; Mass Spectrometry; Minocycline; Reference Standards; Tablets; Therapeutic Equivalency | 2001 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2006 |
A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India.
Topics: Adolescent; Adult; Child; Child, Preschool; Clarithromycin; Female; Humans; India; Leprosy, Paucibacillary; Male; Middle Aged; Minocycline; Ofloxacin; Recurrence; Rifampin; Survival Analysis; Treatment Outcome | 2011 |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Infant; Infant, Newborn; Male; Minocycline; Mutation; Mycoplasma pneumoniae; Naphthyridines; Pneumonia, Mycoplasma; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Outcome | 2013 |
[Minocycline quadruple versus tailored therapy in retreatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Colony Count, Microbial; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Dyspepsia; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Minocycline; Retreatment; Time Factors; Treatment Outcome | 2015 |
82 other study(ies) available for clarithromycin and minocycline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests | 2007 |
Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; RNA, Ribosomal, 23S | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.
Topics: Anti-Bacterial Agents; Cells, Cultured; Epidermal Cells; Epidermis; Humans; Inflammation; Interleukin-8; Keratinocytes; Receptor, PAR-2; Tetracyclines | 2009 |
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
Topics: Microbial Sensitivity Tests; Mycoplasma genitalium; Polymerase Chain Reaction | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages.
Topics: Anti-Infective Agents; Clarithromycin; Drug Combinations; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Quinolones | 1992 |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin | 1992 |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis.
Topics: Animals; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Mice; Minocycline; Toxoplasmosis, Animal | 1992 |
Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Minocycline; Toxoplasmosis, Animal | 1992 |
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins | 1991 |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.
Topics: Animals; Clarithromycin; Drug Therapy, Combination; Erythromycin; Leprosy; Mice; Minocycline; Mycobacterium leprae; Rifampin | 1991 |
Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
Topics: Animals; Anti-Infective Agents; Clarithromycin; Dapsone; Drug Therapy, Combination; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Minocycline; Quinolones; Rifampin | 1995 |
Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Drug Combinations; Female; Humans; Male; Minocycline; Salvage Therapy; Toxoplasmosis | 1995 |
In vitro susceptibility of recently isolated respiratory tract pathogens to minocycline and comparable antibiotics. A multicentre study.
Topics: Adult; Amoxicillin; Bacteria; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acids; Doxycycline; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Minocycline; Moraxella catarrhalis; Respiratory System; Streptococcus pneumoniae | 1994 |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Topics: AIDS-Related Opportunistic Infections; Animals; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mice; Minocycline; Pyrimethamine; Sulfamethoxazole; Toxoplasma; Toxoplasmosis, Animal | 1994 |
Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
Topics: Animals; Clarithromycin; Drug Therapy, Combination; Female; Mice; Minocycline; Mycobacterium leprae | 1994 |
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Rifabutin; Rodent Diseases; Spleen; Time Factors; Tuberculosis | 1993 |
Combination antibiotic treatment with clarithromycin for human immunodeficiency virus-associated Rhodococcus equi infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Drug Therapy, Combination; Female; Humans; Minocycline; Rhodococcus equi | 1993 |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Clarithromycin; Coccidiostats; Drug Combinations; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Kinetics; Mice; Minocycline; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1993 |
Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Doxycycline; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Mice, Inbred BALB C; Minocycline; Paromomycin; Tetracyclines | 1993 |
[Maintenance treatment of cerebral toxoplasmosis in AIDS: role of clarithromycin-minocycline combination].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Minocycline; Toxoplasmosis, Cerebral | 1996 |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1996 |
Clarithromycin for experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Erythromycin; Keratitis; Minocycline; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 1999 |
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii.
Topics: Albendazole; Antifungal Agents; Cell Line; Clarithromycin; Drug Synergism; Etoposide; Humans; Microbial Sensitivity Tests; Minocycline; Pneumocystis; Rifabutin; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Glycogen; Humans; Male; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Plasmids; Urethritis | 2000 |
[Fibrosing alveolitis following Legionella pneumonia].
Topics: Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pulmonary Fibrosis; Pulse Therapy, Drug; Steroids; Treatment Outcome | 2000 |
[Results of antimicrobial susceptibilities of strains clinically isolated at 8 institutions in Hiroshima City to major oral antimicrobial drugs, mainly new quinolone drugs. Hiroshima Levofloxacin Susceptibility Surveillance Group].
Topics: 4-Quinolones; Administration, Oral; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Lactams; Minocycline; Pseudomonas aeruginosa | 2000 |
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline.
Topics: Animals; Antimalarials; Cattle; Cell Line; Clarithromycin; Drug Therapy, Combination; Epithelial Cells; Humans; Lactoferrin; Minocycline; Parasitic Sensitivity Tests; Pneumocystis; Pyrimethamine | 2000 |
Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Dermatomyositis; Drug Resistance, Microbial; Female; Humans; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
Chlamydia pneumoniae resists antibiotics in lymphocytes.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cells, Cultured; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Female; Fluoroquinolones; Humans; Lymphocytes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2003 |
[A case of pulmonaly bulla infection with Mycobacterium fortuitum].
Topics: Aged; Blister; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Lung Diseases, Interstitial; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pulmonary Emphysema | 2003 |
[A case of lung infection due to Mycobacterium abscessus].
Topics: Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Radiography; Sputum; Tuberculosis, Pulmonary | 2003 |
Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Clarithromycin; Enoxacin; Epithelial Cells; Erythromycin; Fibroblast Growth Factors; Gingiva; Humans; Integrins; Keratins; Laminin; Lethal Dose 50; Minocycline; Ofloxacin; Proteins; Roxithromycin; Tetracycline | 2004 |
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].
Topics: Adult; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Female; Forearm; Hand Dermatoses; Humans; Levofloxacin; Lymphadenitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Ofloxacin; Skin; Skin Diseases, Bacterial; Sporotrichosis; Treatment Outcome | 2004 |
A successfully treated case of mycetoma due to Nocardia veterana.
Topics: Adult; Amikacin; Cilastatin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Imipenem; Minocycline; Mycetoma; Nocardia; Occupational Diseases; Treatment Outcome | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
A case of Rothmann-Makai panniculitis successfully treated with tetracycline.
Topics: Anti-Bacterial Agents; Arm; Clarithromycin; Facial Dermatoses; Fat Necrosis; Female; Humans; Leg Dermatoses; Middle Aged; Minocycline; Panniculitis, Nodular Nonsuppurative; Roxithromycin; Tetracyclines; Thorax | 2006 |
A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics.
Topics: Anti-Bacterial Agents; Bronchial Diseases; Bronchoscopy; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Minocycline; Radiography; Sarcoidosis; Time Factors; Treatment Outcome | 2006 |
Mycobacterium mucogenicum: report of a skin infection associated with etanercept.
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Clarithromycin; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Middle Aged; Minocycline; Mycobacterium Infections; Opportunistic Infections; Receptors, Tumor Necrosis Factor; Skin Diseases, Bacterial; Tumor Necrosis Factor-alpha | 2008 |
The intracellular accumulation of phagocytic and epithelial cells and the inhibitory effect on Chlamydophila (Chlamydia) pneumoniae of telithromycin and comparator antimicrobials.
Topics: Anti-Bacterial Agents; Cell Line; Chlamydophila pneumoniae; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Minocycline; Phagocytes | 2008 |
Cat scratch disease with encephalopathy in a 9-year-old girl.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Bartonella henselae; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cat-Scratch Disease; Cats; Ceftriaxone; Child; Clarithromycin; Drug Therapy, Combination; Encephalitis; Erythromycin; Female; Humans; Lymphadenitis; Minocycline; Thienamycins; Treatment Outcome | 2008 |
Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.
Topics: Animals; Anti-Infective Agents; Biofilms; Ciprofloxacin; Clarithromycin; Humans; Lactoferrin; Microbial Sensitivity Tests; Minocycline; Porphyromonas gingivalis; Prevotella intermedia | 2009 |
Subcutaneous nodules with sporotrichoid spread.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Ethambutol; Female; Fishes; Forearm; Gardening; Hand Dermatoses; Hobbies; Humans; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Skin Diseases, Bacterial; Sporotrichosis; Water Microbiology | 2009 |
Prolonged Mycoplasma pneumoniae infection in an elderly patient with community-acquired pneumonia.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Female; Frail Elderly; Humans; Minocycline; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Sputum | 2009 |
Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Minocycline | 2009 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Mycobacterium abscessus infection complicating a professional tattoo.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Minocycline; Mycobacterium; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tattooing; Young Adult | 2010 |
Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Injections, Intravenous; Lymphangitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Tigecycline; Tobramycin; Treatment Outcome | 2011 |
[Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia; Chlamydia Infections; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Infertility, Female; Josamycin; Microbial Sensitivity Tests; Minocycline; Mycoplasma; Mycoplasma Infections; Roxithromycin; Spectinomycin; Tetracycline; Ureaplasma urealyticum; Urogenital System; Young Adult | 2011 |
Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents.
Topics: Adult; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Arthritis, Rheumatoid; Bacterial Typing Techniques; Clarithromycin; Ethambutol; Female; Fingers; Fishes; Hand Dermatoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifabutin; Skin Diseases, Bacterial; Tumor Necrosis Factor-alpha | 2011 |
Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Taiwan; Tigecycline | 2013 |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy.
Topics: Amikacin; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Child, Preschool; Clarithromycin; Female; Humans; Laryngostenosis; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline; Tomography, X-Ray Computed; Tracheostomy; Tuberculosis, Pulmonary | 2014 |
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Azathioprine; Biological Products; Clarithromycin; Drug Substitution; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Infliximab; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prednisone; Skin Diseases, Bacterial; Tigecycline; Tumor Necrosis Factor-alpha | 2014 |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.
Topics: Animals; Antifungal Agents; Azithromycin; Clarithromycin; Drug Combinations; Drug Synergism; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Pythiosis; Pythium; Tigecycline | 2014 |
New insights into the in vitro susceptibility of Pythium insidiosum.
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Clarithromycin; Doxycycline; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Pythium; Tigecycline | 2014 |
Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital.
Topics: Bacterial Toxins; Bacterial Typing Techniques; Cefotaxime; Chromosomes, Bacterial; Clarithromycin; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterotoxins; Exotoxins; Humans; Interspersed Repetitive Sequences; Japan; Leukocidins; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcal Infections; Superantigens; Tertiary Care Centers; Virulence Factors | 2015 |
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moxifloxacin; Peptic Ulcer; Risk Factors; Young Adult | 2015 |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum.
Topics: Animals; Antifungal Agents; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Minocycline; Multivariate Analysis; Pythiosis; Pythium; Rabbits; Skin; Tigecycline | 2016 |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro.
Topics: Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Tigecycline; Time Factors | 2016 |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline | 2017 |
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Minocycline; Mycoplasma pneumoniae; Naphthyridines; Pneumonia, Mycoplasma; Treatment Outcome | 2017 |
Cutaneous Mycobacterium chelonae in a 95-year-old woman.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arm; Clarithromycin; Female; Humans; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 2017 |
Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Female; Fish Diseases; Male; Minocycline; Mycobacterium chelonae; Mycobacterium Infections; Tigecycline; Time Factors; Zebrafish | 2017 |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Taiwan; Tertiary Care Centers; Tigecycline | 2017 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
Topics: Animals; Asymptomatic Infections; Bacterial Load; Clarithromycin; Drug Combinations; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Minocycline; Moxifloxacin; Mycobacterium leprae; Post-Exposure Prophylaxis; Rifampin | 2020 |